Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Caliper - Labchip XT/XTe

Product Image
Product Description

Advanced Nucleic Acid Size Selection and Collection

•    Reduce wasted "non-align" reads with tight size selection
•    Increase average read length by excluding shorter fragments
•    Faster sample processing maximizes use of sequencer
•    Reduce waste and exposure to harmful reagents

The LabChip XT performs fast, automated nucleic acid fractionation accurately and reproducibly using Caliper's proprietary microfluidics. The resulting sample is tightly sized and is delivered in a sequencing compatible buffer. The XT improves laboratory efficiency and provides sizing that is difficulty to obtain using manual methods. Data is displayed digitally and non-fractionated sample can be recollected and used at another time.

Current next generation sequencing workflows have numerous manual processes that bottleneck throughput and contribute to process inefficiency. One of the most time consuming tasks is gel-based size-selection during the library generation process. In addition to being labor intensive and not scalable, manual methods introduce run-to-run and operator-to-operator variability. Furthermore, the imprecision of this manual excision results in the size selection precision (width of the selected band) being typically no better than ± 10% of the median fragment size (e.g. 400 bp ± 40 bp).

Application

•    Next Generation Sequencing Technologies (NextGen Sequencing)
•    Electrophoretic Fractionation
•    DNA Electrophoresis
•    RNA Electrophoresis
•    PCR Sequencing
•    Nucleic Acid Collection
•    Nucleic Acid Electrophoresis
•    Nucleic Acid Fractionation
•    Nucleic Acid Quantification
•    Nucleic Acid Size Selection
•    Sequencing Library Preparation

Product Caliper - Labchip XT/XTe
Company Caliper Life Sciences
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Caliper Life Sciences
68 Elm Street Hopkinton, MA 01748 USA

Tel: 1.508.435.9500
Fax: 1.508.435.3439



Scientific News
Unravelling the Metastatic Mechanism of Melanoma
Research has uncovered the mechanism of melanoma spreading; the findings could lead to a cure for the disease.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
All patients with high levels of one immune-cell type responded to treatment.
Effects of Chemotherapy on Developing Ovaries in Female Fetuses
Researchers at University of Edinburgh have shown that etoposide can damage the development of the ovaries while a fetus is in the womb.
Breast Tumors Evolve in Response to Hormone Therapy
Researchers have suggested that analyzing a single sample of the breast tumor is insufficient for understanding how a patient should best be treated.
Cutting off the Cancer Fuel Supply
Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University has identified a new approach to cancer therapy in cutting off a cancer cell’s ‘fuel supply’ by targeting a cellular survival mechanism known as autophagy. The co-corresponding authors of the work are Rutgers Cancer Institute Deputy Director Eileen P. White, PhD, and researcher ‘Jessie’ Yanxiang Guo, PhD.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!